About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, September 19th, 2014

The QualityStocks
Daily Stock List

graphic
graphic

GeoVax Labs, Inc. (GOVX)

IRGnews Alert reported previously on GeoVax Labs, Inc. (GOVX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed GeoVax Labs, Inc. is a biotechnology company developing vaccines to prevent, and treat, Human Immunodeficiency Virus (HIV) infections. At present, its vaccines are being tested in human clinical trials, for preventive and therapeutic applications. On the whole, GeoVax's vaccines, in various doses and combinations, have been tested in nearly 500 humans. GeoVax Labs is based in Smyrna, Georgia.

The Company’s vaccine technology was developed in association with researchers at Emory University, the NIH, and the CDC. The technology developed by the collaboration is exclusively licensed to GeoVax Labs from Emory University. In addition, GeoVax has non-exclusive licenses to certain patents owned by the NIH.

The design of the Company’s unique, two component vaccine, a recombinant DNA and a recombinant modified vaccinia Ankara (MVA), is to stimulate anti-HIV antibody and anti-HIV T cell immune responses. Its DNA and MVA vaccines are used in a prime/boost protocol in which priming is done with the DNA and boosting with the MVA.

Both the DNA and MVA express the three major proteins of the HIV virus: Gag, Pol, and Env, and produce non-infectious virus-like-particles. GeoVax Labs vaccines are unique in expressing virus-like particles, which display the native form of the trimeric membrane-bound HIV-1 envelope glycoprotein.

Clinical trials for the Company’s preventive HIV vaccines have been conducted by the U.S. National Institutes of Health-supported HIV Vaccine Trials Network (HVTN) with funding from the National Institute of Allergy and Infectious Disease (NIAID).

GeoVax earlier completed the first Phase 1 trial (GV-TH-01) investigating the therapeutic potential of its DNA/MVA vaccine regimen (GOVX-B11) in HIV-infected patients. It announced preliminary results of the trial in early 2014. GeoVax expects to formally publish the full study results for GV-TH-01 in a scientific journal in late 2014.

Regarding its Preventive HIV Vaccine Program, all of the human clinical trials of GeoVax Labs preventive HIV vaccines have been conducted by the HIV Vaccine Trials Network (HVTN) with funding from the NIH. The most recent of these clinical trials (HVTN 094), a Phase 1 study of GOVX-B21, was completed in late 2013. Based on analysis of all available data generated so far, the Company is advancing GOVX-B11 to the next stage of human clinical testing. The Company is in planning discussions with the HVTN and NIH for a Phase 2b efficacy trial. 

GeoVax Labs, Inc. (GOVX), closed Friday's trading session at $0.22, down 6.38%, on 45,555 volume with 24 trades. The average volume for the last 60 days is 32,886 and the stock's 52-week low/high is $0.19/$0.97.

Creative Learning Corp. (CLCN)

SmallCapFinancialWire reported last week on Creative Learning Corp. (CLCN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Creative Learning Corp. is the owner and developer of highly-popular children’s education and enrichment programs. These include Bricks 4 Kidz®, Challenge Island®, and Sew Fun Studios®. The Company offers educational and enrichment programs to children ages 3-12+. Creative Learning operates in 32 countries. The Company lists on the OTC Bulletin Board and has its corporate headquarters in St. Augustine, Florida.

Creative Learning has a unique franchise business model that includes a proprietary curriculum and marketing strategies, plus a proprietary Franchise Marketing Tool (FMT). The Company provides a broad array of programs designed to enhance students’ problem solving and critical thinking skills.

The franchised children’s activity program Bricks 4 Kidz® (BFK) is based on the operation of after-school classes in preschools, elementary schools and middle schools, in-school field trips, camps, birthday parties and other activities using LEGO® bricks as the foundation for hands-on activities. Students design and build interesting and challenging projects using LEGO® bricks and other products.

Earlier this month, the Company announced that its Bricks 4 Kidz® concept has arrived in Ireland, Brunei and Honduras. In addition, it announced this month that it has promoted Mr. Richard Nickelson to Chief Financial Officer (CFO). Mr. Nickelson has served as Creative Learning’s Controller for the past 2.5 years. As Controller he managed all aspects of corporate finance and Securities and Exchange Commission (SEC) reporting. Previously, he held the Controller position for the franchise company, Ellianos Coffee Company. Before that Mr. Nickelson served in key accounting positions at a number of companies. These included a natural gas supplier and an automated manufacturer of architectural millwork.

Moreover, this week, Creative Learning announced that it awarded its 614th franchise, located in North Dublin, Ireland. Mr. Brian Pappas, Chief Executive Officer of Creative Learning stated, “We’re all excited here as we get closer to our target of 650 franchises by the end of the calendar year, and look forward to wrapping up our fiscal year on another high note.”

Creative Learning Corp. (CLCN), closed Friday's trading session at $2.10, even for the day. The average volume for the last 60 days is 7,942 and the stock's 52-week low/high is $1.51/$3.04.

Pazoo, Inc. (PZOO)

Pumps and Dumps, Greenbackers, SmallCapVoice, Daily Stock Motion, Penny Pick Insider, Penny Stocks VIP, PennyStocks24, Stock Shock and Awe, Fast Money Alerts, and Penny Stock General reported earlier on Pazoo, Inc. (PZOO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pazoo, Inc. delivers information, services, and products through direct response digital and TV, retail stores, and its website. Its www.pazoo.com site is a health and wellness social community. Pazoo centers on empowering individuals with the tools to enrich their lives. Pazoo was founded by Mr. David M. Cunic, a successful physical therapist and personal trainer. Founded in 2010, Pazoo has its headquarters in Whippany, New Jersey and the Company lists on the OTCQB. 

Pazoo focuses on delivering easy-to-understand information and on competitively priced products through relationships with leading vendors in the health improvement and pet supplies industries. The Company’s team of medical, fitness, nutritional, and pet experts’ works to enhance its customers' wellbeing through presenting a limited, but high quality selection of merchandise. These include fitness consumables, nutritional supplements, apparel, and wellness/safety products for pets.

Pazoo has teamed up with award winning fitness distributor Acacia.  Acacia is an RLJ Entertainment, Inc. brand (RLJE). Acacia has agreed to supply Pazoo with health and wellness videos and content. This enhances the website and provides important information to the Pazoo audience. Acacia is a leading producer of original and award-winning yoga, fitness, and wellness DVD programming. Pazoo will feature clips from an assortment of Acacia's acclaimed instructors.

In June, Pazoo reported it launched its online medical marijuana magazine "Cannabis Authority". The online magazine commences as a monthly publication and is online at www.cannabisauthority.net. Pazoo has been partnering with individuals and companies in the medical marijuana space to provide the most current content on the benefits and dangers of this industry. The Company will remain neutral and not take a position on this subject.

In addition, Pazoo expects to roll out a number of industry specific publications. The next publication to be rolled out by the end of Q3 2014 is expected to be a military health and wellness-based magazine.

Last week, Pazoo announced it has again expanded its number of Health and Wellness Experts who share their knowledge, insight and expertise with www.pazoo.com visitors. The latest additions to the www.pazoo.com expert section include Dr. Andrew Vertson, Physical Therapy Expert; Jacob Trowbridge, Comedy Expert; Ilana Muhlstein, Nutrition and Healthy Living Expert; Jenna Lowthert, Greif Expert; Tricia Rosenkilde, Photography Expert; and Zia Inman, Essential Oils Expert. 

Pazoo, Inc. (PZOO), closed Friday's trading session at $0.046, up 53.33%, on 672,024 volume with 23 trades. The average volume for the last 60 days is 460,777 and the stock's 52-week low/high is $0.0121/$0.065.

MEDL Mobile Holdings, Inc. (MEDL)

TheMicrocapNews reported earlier on MEDL Mobile Holdings, Inc. (MEDL), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Based in Fountain Valley, California, MEDL Mobile Holdings, Inc. develops, acquires and publishes a growing library of mobile applications (apps). These apps perform particular functions for the user on the Apple and Android platforms. MEDL has entered into partnerships to mobilize and monetize Intellectual Property (IP) with such prominent names as Cheech & Chong, Encyclopedia Britannica, Marlee Matlin, Media Rights Capital, and Real Madrid. MEDL Mobile Holdings’ shares trade on the OTC Markets’ OTCQB.

The Company is establishing a business model in which it expects to generate multiple revenue streams. These streams include development fees, download and in-app purchases, advertising, sponsorship, and licensing of technology. MEDL Mobile's Software Development Kit (SDK) consists of an expanding collection of tools that have been designed to help developers to better market and monetize mobile applications.

MEDL Mobile has joined forces with Specific Media to supply mobile video advertising for MEDL Mobile's previously launched social media platform, "Hang w/." The Hang w/ platform allows live real-time video to be broadcast from one phone to many. Broadcasters earn a percentage of the advertising revenue generated based upon the number of followers who are "Hanging w/" them. Anyone with an iPhone or Android device can connect immediately to an enormous base of fans by way of live-streaming video broadcasts.

The agreement gives Specific Media the exclusive rights to sell all unfilled advertising on the platform. MEDL Mobile Holdings retains the rights to collaborate directly with brands and advertising agencies to sell advertising and sponsorship for individual celebrities and for Hang w/ "channels" of content. MEDL is the largest shareholder of Hang With, Inc.

MEDL Mobile announced in August the release of a beta version of Hangwith.com, which now enables users to experience a broad array of functionality of the Hang w/ platform also on their desktop and laptop computers. This update also allows users of tablets such as the Window Surface Tablet to enjoy the breadth of Hang w/ technology.

In addition, in August, MEDL Mobile Holdings issued its financial report for Q2 2014, ending June 30, 2014. Net revenues increased to $589,102 for the three months ending June 30, 2014, versus $409,955 for the three months ending June 30, 2013. This represents an increase of $179,147 or 44 percent.

Gross profit increased to $240,953 in Q2 2014, versus a gross profit of $64,827 for Q2 2013. This represents an increase of $176,126 or 272 percent. The Company’s net Loss decreased to $487,272. This represents an improvement of $347,842 or 42 percent.
 
Recently, MEDL Mobile announced that MMA Welterweight Contender, Jake Ellenberger, joined the Hang w/ platform as an official spokesperson. He is using the application to give fans worldwide a never-before-seen live behind the scenes view of what it takes to fight competitively at the highest level.

MEDL Mobile Holdings, Inc. (MEDL), closed Friday's trading session at $0.184, up 4.55%, on 118,171 volume with 20 trades. The average volume for the last 60 days is 61,749 and the stock's 52-week low/high is $0.12/$0.48.

Nhale, Inc. (NHLE)

Wall St Report, TradeThesePicks, AskSlapper, Top Stock Tips, Investor News Source, Greenbackers, and AimHighProfits reported earlier on Nhale, Inc. (NHLE), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

Nhale, Inc. is a technology company that plans to launch commercial products in the consumer marketplace. It plans to do this while focusing on the adoption of vaporizing and electronic cigarettes by the world's 1 billion-plus smokers and the decriminalization and legalization of marijuana for medicinal or recreational purposes. The Company has its Nhale vaporizer pen product. In addition, Nhale plans to become a leading provider of cannabis cultivation systems and products in the United States. Nhale is based in Houston, Texas and the Company lists on the OTC Bulletin Board.

In a vaporizer pen, a battery-powered atomizer heats dry herb, wax or e-liquids, until the compound’s active ingredient becomes a gaseous vapor. The Company’s Nhale vaporizer pen is an advanced vaporizer. It comes in a complete multi-purpose kit. This kit includes everything required for vaporizing dry leaf herbs, waxes, oils and e-liquids. A user fills the chamber with dry herb, holds down the power button and inhales lightly. The Nhale vaporizer pen measures 6 1/4" long and 1/2" thick. The vaporizer heats dry herbs instead of burning them. An optional glass cartridge allows for the use of e-liquids and aromatic/therapeutic oils.

Nhale has brought Evaps Distribution and Promotions on board. Evaps is taking over the marketing and sales of Nhale’s vaporizer pen line. Nhale is in the process of expanding its operations, diversifying to other products in the space. In July, Nhale brought the new distributor on board who placed an initial 10,000-unit order. Nhale has since signed an assortment of retailers who will sell Nhale’s vape pen kits, including twelve new retail locations in Greater Houston.

Recently, Nhale announced it is continuing to explore innovations in the cannabis business space. The Company is focusing on some of the most promising trends, including cultivation technology, infused products, and packaging. Nhale is investigating responsible business opportunities and engaging with industry experts. Nhale’s focus is shifting to cultivation and the company is immediately entering the grow container technology space. Grow containers are climate-controlled indoor agricultural chambers. The design of them is to create an ideal year-round growing environment. 

This week, Nhale announced the upcoming launch of Growpod. This is an advanced cultivation technology, which will allow growing cannabis under optimum, high tech conditions. Growpod is a modern, self-contained grow environment that is economical, efficient and secure. Closed modular cultivation systems such as the one being developed by Nhale enable growers to develop high density facilities. These facilities will speed up access to a healthy and secure supply of affordable, high quality product. These facilities will do it more efficiently and economically than traditional grow operations.

Nhale, Inc. (NHLE), closed Friday's trading session at $0.55, up 5.77%, on 17,527 volume with 20 trades. The average volume for the last 60 days is 35,399 and the stock's 52-week low/high is $0.14/$1.33.

Premier Alliance Group, Inc. (PIMO)

Stocks That Move, PennyStocks24, Wall Street Resources, Alliance Advisors, and SmallCap Network reported earlier on Premier Alliance Group, Inc. (PIMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

New York, New York-based Premier Alliance Group, Inc. is a foremost provider of Cybersecurity, Energy, and Business Advisory Solutions. Since 1995, the Company has been delivering results that improve productivity, mitigate risk, as well as maximize profits. It offers its clients holistic solutions to ensure their success, from immediate, tactical problem-solving to long-term strategic planning in the central areas of Cybersecurity, Energy & Sustainability, Governance, Risk and Compliance, and Operations. Premier Alliance Group’s shares trade on the OTC Markets’ OTCQB.

The Company’s clients range in size from Fortune 100 companies to mid-sized and owner-managed businesses across a span of industries. These include local, state and federal government agencies.

Premier Alliance Group’s subsidiary is “root9B”. This subsidiary is a provider of cyber security and advanced technology training capabilities, operational support and consulting services. root9B’s workforce comprises US military and Law Enforcement veterans with wide-ranging experience providing advanced technology solutions. root9B personnel conduct advanced vulnerability analysis, penetration testing, digital forensics, incident response, industrial control system (ICS) security, and active adversarial pursuit (HUNT) engagements on networks globally.

Regarding Energy, Premier Alliance Group’s Energy and Controls Solutions Group is a leading integrator of solutions in energy management, sustainability, and automation controls. It delivers results that reduce energy usage, lower operating costs, improve productivity, and maximize value, and accomplishes this by way of independent analysis and adherence to quality standards.

The Company’s Business Advisory Solutions Group provides business solutions, which concentrate on core processes, such as project management, business assessment & analysis, and governance, risk and compliance that deliver measurable bottom line results.

Last week, Premier Alliance Group announced that The United States Department of Energy (DOE) added the Company to its list of Qualified Energy Service Companies. The decision by the DOE allows Premier Alliance to compete for and execute unique cybersecurity services to a critical piece of the U.S. infrastructure and provide Energy Savings Performance Contracting for Federal agencies.

This week, Premier Alliance Group subsidiary, root9B, announced that Mr. John Harbaugh, a former senior executive for the National Security Agency (NSA), has been appointed Chief Operating Officer (COO) of root9B, effective immediately. Mr. Harbaugh has 25+ years of varied experience within the cryptologic and intelligence community as a member of the U.S. Military, and as a senior executive for the NSA.

Premier Alliance Group, Inc. (PIMO), closed Friday's trading session at $0.98, down 9.26%, on 179,072 volume with 106 trades. The average volume for the last 60 days is 57,495 and the stock's 52-week low/high is $0.45/$1.24.

China Fruits Corp. (CHFR)

ResearchOTC, StockBomb.com, StockLockandLoad, StockRockandRoll, and PennyStockLocks.com reported earlier on China Fruits Corp. (CHFR), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

China Fruits Corp. is a holding company that lists on the OTC Markets’ OTCQB. The Company engages in manufacturing, trading and distributing fresh tangerines and other fresh fruits in the People's Republic of China (PRC). China Fruits wholly owns two subsidiaries. One is Taina International Fruits (Beijing) Co., Ltd. Taina is building and operating franchise retail stores. The second is Jiangxi Taina Nanfeng Orange Co., Ltd. Jiangxi is operating a 782,765-square-foot manufacturing base in Jiangxi Province's Nanfeng County.

China Fruits owns a 98,505-square-foot Express Export Zone in Nanfeng, with an air-adjusted and fresh-keeping warehouse, and an advanced photoelectric fruit sorter. In Beijing, China Fruits has a 26,700-square-foot distribution center and 19 franchise retail stores throughout the city.

The Company is strengthening the branded franchise fruit retail stores and entrenching itself in this niche. From the very start of its business, China Fruits has been awarded with the "National Leading Enterprise of Agriculture Industrialization", "China's Most Influential Fruit Brand", "Leading Fruit Enterprise", and "Top Ten Most Trustable Enterprise" awards, among other awards.

China Fruits announced this past July that it decided to open its flagship store in Tmall, a leading third-party platform for brands and retailers. This would be a major step entering the Chinese domestic fruit e-commerce. Tmall is one of the popular e-commerce platforms associated with Alibaba. The Company’s strategic plan also includes further expanding its fruit e-commerce business to the leading business-to-consumer platforms such as JD.com, Yhd.com, and other major group-buying websites. 

Mr. Quanlong Chen, China Fruits’ Chairman and Chief Executive Officer, said in July, "The huge traffic and high user trust of Tmall could enable the Company to make a major breakthrough into the domestic fruit e-commerce. Through Tmall's mature technical platform and high quality customer service, we are now establishing basis for future branding and official website traffic attracting."

In mid-August, China Fruits announced financial results for Q2 2014. Revenues for the six months ended June 30, 2014 were $10,551,692. This represents a 562 percent increase from the corresponding period in 2013. Operating income for Q2 was $430,249, versus an operating loss of $150,212 in the same period the year prior. Gross margin was 29.80 percent in Q2. This represents a 60 percent increase from the corresponding period in 2013.

Net income attributable to the Company’s shareholders was $315,656. This represents a 1515 percent increase from the corresponding period in 2013. Fully diluted earnings per share (EPS) were $0.01, versus EPS of $0.0004 in the same period the year prior.

China Fruits Corp. (CHFR), closed Friday's trading session at $0.14, down 26.32%, on 52,200 volume with 10 trades. The average volume for the last 60 days is 24,584 and the stock's 52-week low/high is $0.013/$0.59.

graphic

The QualityStocks
Company Corner

graphic
graphic

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $8.00, even for the day, on 711 volume with 2 trades. The stock’s average daily volume over the past 60 days is 27, and its 52-week low/high is $5.00/$17.80.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.

AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Receives Notice of Allowance for Canadian Patent Further Expanding Stem Cell Technology Platform

VistaGen Announces Reverse Stock Split

VistaGen Receives Notice of Allowance for Canadian Patent Expanding Stem Cell Technology Platform

Sibling Group Holdings, Inc. (SIBE)

The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.178, up 18.67%, on 44,470 volume with 15 trades. The stock’s average daily volume over the past 60 days is 49,504, and its 52-week low/high is $0.031/$0.24.

Sibling Group Holdings, Inc. (SIBE) is enhancing and delivering 21st century learning with advanced technology and education management operations. Accessing funds from the public capital markets is part of the company’s unified strategy to accelerate the improvement of Pre-K, K-12 and post-secondary education around the world. Better educated children and adults, sustainable and cost effective instructional models, and reduced dependence on governmental funding are the end results.

Existing offerings include professional development for the teaching profession; educational technology, including classroom management tools; a comprehensive and flexible online curriculum; an aggregation platform for massive open online courses, and academic and skills credentialing. Investments are being made in specialized curriculum such as STEM (science, technology, engineering and math), ESL (english as a second language), SEL (social and emotional learning), and Special Ed aimed at supporting students with special needs and their teachers.

Sibling Group is acquiring various Ed-tech businesses and components with the goal of building the first complete solution for the delivery and management of educational content, and tracking educational results, in the digital media – from curriculum to course certification. The recent acquisition of Blended Schools Network (BSN), which serves over 160 school districts with 300,000 course enrollments and currently offers 212 different online courses, is a great example and has provided Sibling Group with extensive infrastructure and solid groundwork for growth in a rapidly growing industry.

IBIS Capital is forecasting fifteen-fold growth in the e-learning market over the next 10 years and has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever observed in the media industry. With a strong, highly experienced management team, Sibling Group is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer

Sibling Group Holdings, Inc. Company Blog

Sibling Group Holdings, Inc. News:

Sibling's BSN Division Launches Teacher Professional Development on Udemy Global Marketplace

Sibling Group Holdings to Present at the National Investment Banking Association Investment Conference

Sibling Group Holdings, Inc. (SIBE) Announces Engagement of QualityStocks Investor Relations Services

Ecrypt Technologies, Inc. (ECRY)

The QualityStocks Daily Newsletter would like to spotlight Ecrypt Technologies, Inc. (ECRY). Today, Ecrypt Technologies, Inc. closed trading at $0.135, up 3.85%, on 16,800 volume with 5 trades. The stock’s average daily volume over the past 60 days is 5,657 and its 52-week low/high is $0.09/$0.179.

Ecrypt Technologies, Inc. (ECRY) is an emerging provider of military-strength data security solutions for enterprise, government, and military. The company empowers organizations with the freedom to communicate and collaborate without risk of liability, reputation damage, competitive threat, and other negative outcomes. Ecrypt is the trusted first choice for those looking to keep their communications confidential.

Today’s businesses struggle to guard against the increasing number of dangers as a result of complicated networks built with many different components that are often individually patched to address new threats, while neglecting to close security gaps in traditional solutions. On average, data breaches and subsequent fines and litigation cost a US business $534 million every year, the highest in the world according to the Ponemon Institute.

The flagship Ecrypt solution is an integrated email and encryption server that can be quickly deployed to fortify the security of corporate communication, including attachments and mobile devices, against data breaches while eliminating phishing threats, malware infections, and spam. By using Ecrypt’s paradigm-shifting technology, companies alleviate the need for separate encryption servers with their associated bloated administration and multiple points of weakness.

Ecrypt is well positioned to benefit from increasingly demanding data confidentiality regulations such as the Health Insurance Portability and Accountability Act (HIPAA), the Federal Information Security Management Act (FISMA), and Gramm-Leach-Bliley Act (GLBA). As a result of extensive market research and working directly with organizations in multi-billion dollar industries, the company fully understands the business community’s need to maintain confidentiality, prevent data breaches, comply with government regulations, and mitigate litigation risks. Disclaimer

Ecrypt Technologies, Inc. Blog

Ecrypt Technologies, Inc. News:

Ecrypt Technologies Inc.'s Chief Executive Officer, Dr. Thomas A. Cellucci, is the First American Elected to EECSA's Board

Safe America Appoints Ecrypt CEO to Head Drive

Ecrypt Technologies and Cicada Security Technology Enter into a Marketing Alliance

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.008, up 14.29%, on 394,770 volume with 2 trades. The stock’s average daily volume over the past 60 days is 324,175, and its 52-week low/high is $0.0031/$0.02.

Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.

Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.

Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited

Consorteum Holdings Launches New Mobile Results App for Popular Keno Game

Consorteum Holdings Enters Mobile Application Development and Business Agreement With XpertX, Inc.

Pan Global Corp. (PGLO)

The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.0185, up 3.35%, on 118,197 volume with 11 trades. The stock’s average daily volume over the past 60 days is 677,095, and its 52-week low/high is $0.009/$0.96.

Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.

The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.

Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.

Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer

Pan Global Corp. Company Blog

Pan Global Corp. News:

Pan Global, Corp. Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017

Pan Global, Corp. Shareholder Update: Small-Hydro Plant Connected to Power Grid in Northern India

Pan Global, Corp. Increases Equity Stake in 5.7 MW Small-Hydro Plant in Northern India

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.37, up 2.78%, on 173,706 volume with 44 trades. The stock’s average daily volume over the past 60 days is 38,935, and its 52-week low/high is $0.15/$1.00.

Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.

Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.

The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.

Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.

Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer

Zenosense, Inc. Company Blog

Zenosense, Inc. News:

Zenosense, Inc. Update -- MRSA and Lung Cancer Device Development

Zenosense, Inc. Begins Development of Lung Cancer Detection Device

Zenosense, Inc. Highlights Recent Media Coverage of MRSA

Falcon Crest Energy (FCEN)

The QualityStocks Daily Newsletter would like to spotlight Falcon Crest Energy (FCEN). Today, Falcon Crest Energy closed trading at $0.036, up 1.69%, on 21,000 volume with 2 trade. The stock’s average daily volume over the past 60 days is 17,696, and its 52-week low/high is $0.0005/$0.095.

Falcon Crest Energy (FCEN) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.

The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Falcon Crest Energy aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.

Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Falcon Crest Energy has strategically added extensive technical guidance and field management experience.

Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Falcon Crest Energy is well positioned to generate substantial revenues in the short and long term future. Disclaimer

Falcon Crest Energy Company Blog

Falcon Crest Energy News:

Falcon Crest Names Michael Cvetanovic to Advisory Council

Falcon Crest Energy Announces Powder River Basin Leasehold Acquisition

Panther Energy Changes Name to Falcon Crest Energy

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

TheMicrocapNews
(PZOO)

2.

The Street
(BABA)

3.

Streetwise Reports
(UGD.V)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251